An open randomized comparative clinical study of katamkateryadi kwath and phalatrikadi kwath in management of prameh with special refernce to hyperglycemia in type 2 diabetes mellitus

Treatment of Diabetes Mellitus mainly includes the use of Oral Hypoglycaemic Agents (OHAs)

and different types of insulin. Patients have to take these medicines lifelong as per their need.

OHAs possess their own side-effects like sudden hypoglycaemia, G.I.upsets etc. Their major

limitation is primary & secondary failure where patient doesn’t respond to medicines. It

compels the physician to increase the dose, change the medicine or switch over to insulin. The

major concern about these Oral Hypoglycemic Agent is that they are single targetted acting on

specific targets involved in pathology of Diabetes Mellitus, but when we see patients of

Diabetes Mellitus in clinical practice most of time they have many etiological factors involved in

pathology of Diabetes Mellitus hence multi targeted approaches with less adverse reactions

also becomes nessecity in treatement of Diabetes Mellitus. A single herb mentioned in ayurved

contain multiple ingredient, multitargeted approaches with less adverse reactions fulfilling the

above criteria…

There are various formulations in Ayurvedic texts to treat Prameha. It is necessary to study

and evaluate efficacy of medications by scientific research. Therefore, I have selected

KATAMKATERYADI KWATH to evaluate its clinical efficacy with standard drug that is

PHALATRIKADI KWATH.

Here I would be checking patient thoroughly to identify causes of the disease so as to execute

NIDAN PARIVARJAN and shall treat patients with KATAMKATERYADI KWATH or PHALATRIKADI

KWATH as per randomization. I shall follow these patients to note the changes in them with

respect to meda dhatvagni deepan, meda prasadan, prameha lakshanani and mutra (medo

mala) parikshan and blood sugar level study. Evaluation of results will be done at the end of the

trial .